SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001730463-20-000003
Filing Date
2020-05-07
Accepted
2020-05-07 16:41:53
Documents
69
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 6-K autolus-20200331x6k.htm 6-K 46461
2 EXHIBIT 99.1 exhibit991-consolidatedfin.htm EX-99.1 510217
3 EXHIBIT 99.2 exhibit992-operatingresult.htm EX-99.2 161307
  Complete submission text file 0001730463-20-000003.txt   3953836

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT autl-20200331.xml EX-101.INS 598708
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20200331.xsd EX-101.SCH 40248
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT autl-20200331_cal.xml EX-101.CAL 58177
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20200331_def.xml EX-101.DEF 189707
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20200331_lab.xml EX-101.LAB 481038
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20200331_pre.xml EX-101.PRE 317878
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 20857142
SIC: 2836 Biological Products, (No Diagnostic Substances)